Cornelia Ursula Kunz

4PUBLICATIONS
5CO-AUTHORS
Liquid biopsiesSolid tumoursMolecular targetsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 02, 2024
A two-stage group-sequential design for delayed treatment responses with the possibility of trial restart.

Stephen Schüürhuis, Frank Konietschke, Cornelia Ursula Kunz

|Sep 02, 2022
Should the two-trial paradigm still be the gold standard in drug assessment?

Stella Jinran Zhan, Cornelia Ursula Kunz, Nigel Stallard

|Jun 30, 2021
Clinical Trials Impacted by the COVID-19 Pandemic: Adaptive Designs to the Rescue?

Cornelia Ursula Kunz, Silke Jörgens, Frank Bretz

|Sep 28, 2018
An alternative method to analyse the biomarker-strategy design.

Cornelia Ursula Kunz, Thomas Jaki, Nigel Stallard

Pageof 1